At Penn Medicine's Abramson Cancer Center, individuals diagnosed with urethral cancer receive treatment from a multidisciplinary team of nationally recognized experts in urethral cancer diagnosis, treatment and research.
As a national leader in cancer research, patients treated at the Abramson Cancer Center have access to cutting-edge clinical trials and the latest treatment advances. U.S. News & World Report consistently ranks Penn among the best in the nation for cancer services.
Every step of urethral cancer treatment, from diagnosis and treatment, to forming a survivorship plan, comes with different needs and issues that should be addressed.
Oncology navigators are committed to making sure every patient experience is as comfortable as possible. They are experts in navigating complex health care situations and serve as a consistent point of contact and a reliable source for advice, support and direction for patients and families.